Trials / Completed
CompletedNCT00295217
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Clinical Study to Validate the Changes to ExAblate 2000 Device
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 15 (planned)
- Sponsor
- InSightec · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to validate the new ExAblate Application software V4.2 by developing additional data that shows the safety of this treatment. The ExAblate is intended to ablate uterine fibroid tissue in pre- or peri-menopausal women with symptomatic uterine fibroids who desire a uterine sparing procedure. Patients must have a uterine size of less than 24 weeks and not seeking treatment for reasons of improving fertility.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ExAblate 2000 |
Timeline
- Start date
- 2006-02-01
- Completion
- 2006-10-01
- First posted
- 2006-02-23
- Last updated
- 2018-12-20
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00295217. Inclusion in this directory is not an endorsement.